The Cigna Group Reports Strong First Quarter 2025 Results and Raises Full-Year Outlook Amid Continued Growth Across Core Platforms
Global health company The Cigna Group (NYSE: CI) announced robust financial results for the first quarter of 2025, underpinned by disciplined execution and strong performance across its diversified portfolio. The company also raised its full-year outlook, reflecting continued momentum from its core platforms—Evernorth Health Services and Cigna Healthcare.
A Strong Start to the Year Amid Industry Transformation
The Cigna Group reported shareholders’ net income of $1.3 billion for the first quarter of 2025, translating to earnings of $4.85 per share. This marks a sharp turnaround from the net loss of $0.3 billion, or $0.97 per share, in the same quarter of 2024. The significant improvement underscores the company’s ability to navigate a dynamic and evolving healthcare landscape while delivering value for shareholders.
Adjusted income from operations—a key metric used by the company to assess its core performance—came in at $1.8 billion, or $6.74 per share, compared to $1.9 billion, or $6.47 per share, in the first quarter of 2024. The year-over-year per-share increase highlights strong underlying fundamentals and operational efficiency despite the marginal decline in absolute adjusted income.
David M. Cordani, Chairman and Chief Executive Officer of The Cigna Group, emphasized the company’s ongoing transformation and its focus on building a more sustainable and transparent healthcare ecosystem.
“We are building a more sustainable health care model by successfully delivering on our series of commitments and actions to improve transparency and support for our customers and patients,” Cordani said. “Our strong first quarter results and increase in outlook for full-year earnings reflects the strength of our Evernorth Health Services and Cigna Healthcare growth platforms in a dynamic environment.”
Business Highlights: Evernorth and Cigna Healthcare Drive Results
The Cigna Group operates through two principal growth platforms: Evernorth Health Services, which includes pharmacy, care, and intelligence solutions, and Cigna Healthcare, which encompasses U.S. commercial and international health insurance offerings. Both divisions continued to demonstrate resilience and relevance amid shifting healthcare demands, contributing significantly to first-quarter results.
Evernorth Health Services remains a cornerstone of the company’s growth strategy. With a mission to make health care more affordable, predictable, and simple, Evernorth delivers value-driven services to health plans, employers, government organizations, and providers. The platform continues to benefit from long-term partnerships and its integrated approach to pharmacy benefit management, specialty pharmacy, and care coordination.
Cigna Healthcare also posted solid performance during the quarter. The segment has focused on improving access, outcomes, and affordability for its members through tailored benefit plans, expansive provider networks, and digital health tools. The company’s commercial health insurance segment has seen strong employer retention and new client wins, while the international markets have maintained growth momentum in select geographies.
Portfolio Optimization: Medicare Divestiture Completed
A major milestone during the quarter was the successful completion of the previously announced divestiture of The Cigna Group’s Medicare Advantage, Medicare Supplement, and Medicare Part D businesses to Health Care Service Corporation (HCSC). The transaction closed on March 19, 2025.
This divestiture is part of a broader strategy to streamline the company’s operations and sharpen its focus on areas of highest strategic value. By exiting the Medicare business, The Cigna Group aims to reallocate capital to faster-growing and higher-margin opportunities in the employer, government, and international health services sectors.
The company noted that the transaction strengthens its balance sheet and provides flexibility to pursue both organic investments and potential strategic acquisitions aligned with its long-term vision.
Financial Strength and Shareholder Value Creation
The Cigna Group continues to maintain a strong financial foundation, with ample liquidity, disciplined capital management, and a balanced approach to investment. In the first quarter, the company returned capital to shareholders through share repurchases and dividends, reflecting confidence in its business outlook and commitment to long-term shareholder value.
While detailed cash flow and capital deployment figures will be shared in subsequent filings, the company reiterated its ongoing commitment to returning a significant portion of free cash flow to shareholders annually, while maintaining a prudent leverage profile and investment-grade credit ratings.
Raising Full-Year 2025 Outlook
Buoyed by the strong first-quarter performance, The Cigna Group raised its full-year 2025 guidance. The company now expects adjusted income from operations to be in the range of $24.50 to $25.00 per share, up from the prior guidance issued earlier this year. The increase reflects sustained momentum across core platforms, improved operating leverage, and a more focused portfolio post-Medicare divestiture.
Management also cited continued progress in customer engagement, digital transformation, and clinical innovation as contributors to the enhanced outlook.
Positioned for Long-Term Growth
As the healthcare industry undergoes significant transformation—driven by shifting consumer expectations, regulatory developments, and rapid technological change—The Cigna Group is positioning itself at the forefront of innovation. The company continues to invest in advanced analytics, virtual care solutions, value-based care arrangements, and whole-person health initiatives to drive better health outcomes at lower costs.
With more than 190 million customer relationships globally, The Cigna Group remains one of the most expansive and influential healthcare companies worldwide. Its vertically integrated model enables it to capture efficiencies across the value chain while improving access and outcomes for diverse populations.
The company’s mission—to improve the health and vitality of those it serves—remains central to its strategy. Management emphasized that Cigna is not only delivering near-term financial performance but also laying the groundwork for sustainable long-term growth.
The Cigna Group’s first quarter 2025 results underscore the strength of its business model, the resilience of its platforms, and the effectiveness of its strategic execution. With a sharpened portfolio, strong financial performance, and raised full-year outlook, the company is well-positioned to navigate industry headwinds and seize growth opportunities in a rapidly evolving healthcare environment.
A reconciliation of shareholders’ net income to adjusted income from operations is available on the following page and detailed in Exhibit 1 of the earnings release.
About The Cigna Group
The Cigna Group (NYSE: CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Evernorth Health Services, Cigna Healthcare, or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 markets and jurisdictions, and has more than 180 million customer relationships around the world. Learn more at thecignagroup.comThis link will open in a new tab..
